Kyrgyzstan vs Mexico: Treatment success rate for patients treated for MDR-TB
Kyrgyzstan
75.0%
in 2022
Mexico
75.0%
in 2022
Kyrgyzstan rank
70th
Mexico rank
70th
Treatment success rate for patients treated for MDR-TB over time
- Kyrgyzstan
- Mexico
How they compare
Kyrgyzstan currently reports 75.0% against 75.0% in Mexico, a difference of 0.0%.
The two have swapped places 3 times across 17 shared years of data; in 2006 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 70th and Mexico ranks 70th of 163 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 1 and Mexico in 2.
Head to head by decade
| Decade | Kyrgyzstan | Mexico | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 45.8% | 62.2% | 16.5% | Mexico |
| 2010s | 57.1% | 64.6% | 7.5% | Mexico |
| 2020s | 74.0% | 68.7% | 5.3% | Kyrgyzstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kyrgyzstan or Mexico?
- Kyrgyzstan, at 75.0% against 75.0% in Mexico as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kyrgyzstan and Mexico?
- 0.0%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Mexico?
- 17 years are reported by both, from 2006 to 2022.
- How do Kyrgyzstan and Mexico rank globally for treatment success rate for patients treated for mdr-tb?
- Kyrgyzstan ranks 70th and Mexico ranks 70th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.